Exendin-4 Attenuates Hepatic Steatosis by Promoting the Autophagy-Lysosomal Pathway

Dysregulated hepatic steatosis may lead to chronic liver inflammation and nonalcoholic steatohepatitis (NASH). Recent studies have suggested that exendin-4, a glucagon-like peptide-1 agonist, may be a promising therapeutic for hepatic steatosis and NASH. However, the molecular mechanisms underlying...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Hsin-Hsien, Wang, Hao-Chen, Hsieh, Mao-Chih, Lee, Ming-Che, Su, Bor-Chyuan, Shan, Yan-Shen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307340/
https://www.ncbi.nlm.nih.gov/pubmed/35872844
http://dx.doi.org/10.1155/2022/4246086

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307340/
https://www.ncbi.nlm.nih.gov/pubmed/35872844
http://dx.doi.org/10.1155/2022/4246086

Ejemplares similares